Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-06-24
1992-08-25
Tsang, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 69, A61K 3148, C07D45704
Patent
active
051419440
ABSTRACT:
This invention provides N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides useful for blocking 5HT.sub.2 receptors in mammals having an excess of serotonin centrally or peripherally. The invention also provides methods for treating sexual dysfunction, hypertension, migraine, vasospasm, thrombosis, ischemia, depression, anxiety, sleep disorders and appetite disorders with a compound of the invention.
REFERENCES:
patent: 3580916 (1971-05-01), Garbrecht
patent: 4713384 (1987-12-01), Cohen et al.
patent: 4810710 (1989-03-01), Cohen et al.
patent: 4902691 (1990-02-01), Cohen et al.
patent: 4931447 (1990-06-01), Garbrecht et al.
patent: 5043341 (1991-08-01), Cohen et al.
Cohen Marlene L.
Robertson David W.
Conrad Robert A.
Eli Lilly and Company
Tsang Cecilia
Whitaker Leroy
LandOfFree
N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxam does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxam, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxam will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-385230